Sino Biopharmaceutical Dividends and Buybacks
Dividend criteria checks 4/6
Sino Biopharmaceutical is a dividend paying company with a current yield of 1.79% that is well covered by earnings.
Key information
1.8%
Dividend yield
0.9%
Buyback Yield
| Total Shareholder Yield | 2.7% |
| Future Dividend Yield | 2.7% |
| Dividend Growth | 14.2% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | €0.060 |
| Payout ratio | 47% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: SMZ1's dividend payments have been volatile in the past 10 years.
Growing Dividend: SMZ1's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Sino Biopharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (SMZ1) | 1.8% |
| Market Bottom 25% (DE) | 1.8% |
| Market Top 25% (DE) | 4.8% |
| Industry Average (Pharmaceuticals) | 1.3% |
| Analyst forecast (SMZ1) (up to 3 years) | 2.7% |
Notable Dividend: SMZ1's dividend (1.79%) is higher than the bottom 25% of dividend payers in the German market (1.76%).
High Dividend: SMZ1's dividend (1.79%) is low compared to the top 25% of dividend payers in the German market (4.76%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (47.2%), SMZ1's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (18.4%), SMZ1's dividend payments are well covered by cash flows.